Home/ Supplements/ Alpha Lipoic Acid/ OptiMetaboliX Vanilla Delight

OptiMetaboliX Vanilla Delight

product on market Powder XYMOGEN Safety: 97/100
97/100

This product looks safe

  • Niacin: 40mg is 1.1× the Tolerable Upper Intake Level (35mg)
  • Vanadium: 2.5mg is 1.4× the Tolerable Upper Intake Level (1.8mg)
  • 48% of ingredients have research evidence
D Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

The product profile consists of macronutrients including proteins, carbohydrates, and fats, which provide essential energy and structural support for the body. There is strong evidence supporting the role of these nutrients in maintaining metabolic function and muscle health. Evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 40mg is 1.1× the Tolerable Upper Intake Level (35mg)

Vanadium: 2.5mg is 1.4× the Tolerable Upper Intake Level (1.8mg)

Label

Product Label

Label for OptiMetaboliX Vanilla Delight
Open Full PDF View on NIH DSLD →
Details

Label Data

40 Gram(s)
Serving Size
14
Servings
Other Combinations
Product Type
48%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
150 {Calories}
Total Fat
3 Gram(s) (5% DV)
Cholesterol
Total Carbohydrates
10 Gram(s) (3% DV)
Protein
21 Gram(s) (42% DV)
40 mg (200% DV)
Exceeds UL by 1.1× (UL: 35 mg) 196 studies (A:5, B:63)
5 mg (250% DV)
3.8× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
200 mcg (50% DV)
Within RDA (0.5× RDA) 226 studies (A:10, B:105)
50 mcg (833% DV)
20.8× RDA — above typical dose 139 studies (A:1, B:44)
5000 mcg (1667% DV)
166.7× RDA — above typical dose 27 studies (A:0, B:11)
35 mg (350% DV)
7.0× RDA — above typical dose 2 studies — no high-quality reviews
Iron
3.6 mg (20% DV)
150 mcg (100% DV)
Within RDA (1.0× RDA) 245 studies (A:4, B:133)
15 mg (100% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
500 mcg (417% DV)
14.3× RDA — above typical dose 199 studies (A:1, B:55)
Sodium
410 mg (17% DV)
Potassium
40 mg (1% DV)
Brown Seaweed Blend
500 mg
Cinnamon 10:1 aqueous extract
200 mg
Market median: 260.0mg (249 products) 158 studies (A:4, B:61)
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
2.5 mg
Exceeds UL by 1.4× (UL: 1.8 mg) 1 studies (A:0, B:1)
50 mg
41.7× RDA — above typical dose 76 studies (A:0, B:33)

Other Ingredients

VegaPro organic dried Cane syrup Sunflower Oil Natural flavors Aminogen Sea Salt Xanthan Gum Stevia leaf extract
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: Blend, shake, or briskly stir two level scoops (40 g) into 8-12 oz chilled water and consume one to two times daily; or take one to two scoops approximately 20-30 minutes before each main meal (upper limit of six scoops/day); or use as directed by your healthcare practitioner.

Warnings & Precautions

Do not use if tamper seal is damaged.

Consult your healthcare practitioner prior to use.

Not intended for use by pregnant or lactating women or children under 12. Patients taking blood-glucose lowering medication should be monitored for hypoglycemia.

Not intended for use by pregnant or lactating women or children under 12.

STORAGE: Keep closed in a cool, dry place out of reach of children.

Formulation Notes

DOES NOT CONTAIN: Wheat, gluten, yeast, soy, animal or dairy products, fish, shellfish, peanuts, tree nuts, egg, artificial colors, artificial sweeteners, or preservatives.

21g PROTEIN

Additional Information

ZLF-GLYVAN-01 REV. 050913

This package is completely recyclable {recycle}

EXCLUSIVE PROFESSIONAL FORMULAS

For Support of Healthy Glusose and Insulin Metabolism

Pharmaceutical Grade Professional Use Only

100% VEGAN V VegaPro(TM) 100% Gluten Free

Quatrefolic(R)

AMINOGEN(R)

This newly developed, next generation dual carb controller is 100% natural, has an excellent safety profile, and is friendly to the gastrointestinal tract.

Cinnamon has been studied extensively for its roles in supporting healthy glucose uptake, glycogen synthesis, and insulin actin, along with maintaining blood lipids already within the normal range.

STORAGE: Keep closed in a cool, dry place out of reach of children.

Metadata

Product Details

UPC / SKU8 71149 00350 0
DSLD Entry Date2013-12-24
Product TypeOther Combinations
FormPowder
BrandXYMOGEN
DSLD ID28375
Data Updated2026-04-11
Research

Research Evidence

21
Research Sources
52
Avg Quality
13
Rct
4
Meta Analysis
2
Systematic Review
2
Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024 PubMed DOI
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024 PubMed DOI
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024 PubMed DOI
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023 PubMed DOI
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018 PubMed DOI
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012 PubMed DOI
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020 PubMed DOI
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024 PubMed DOI
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024 PubMed DOI
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences PubMed
View all evidence for Alpha Lipoic Acid →
Compare

Similar Products

Fast & Be Clear
Allergy Research Group · Powder
100
Syntha Phase Vanilla
Precision Engineered · Powder
100
Syntha Phase Chocolate
Precision Engineered · Powder
100
Syntha Phase Cookies & Cream
Precision Engineered · Powder
100
DietEz
NutriCology · Powder
100
View all Alpha Lipoic Acid products →
Alpha Lipoic Acid research Best Alpha Lipoic Acid All Alpha Lipoic Acid products More from XYMOGEN View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.